ArticleChina CDC weekly2025
Evaluation of the Long-Term Benefits and Cost-Effectiveness of Colorectal Cancer Screening for Populations with Excess Weight - China, 2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known on this topic?: China has the world's largest population of individuals who are overweight or obese, contributing to the growing burden of colorectal cancer (CRC). Screening is an effective strategy for reducing CRC mortality and incidence. What is added by this report?: Using a simulation model, we found that CRC screening reduces incidence and mortality across all body mass index groups (normal, overweight, and obese) in China, with greater quality-adjusted life-year gains and 6%-14% higher colonoscopy efficiency in individuals who are overweight or obese. Screening proved to be more cost-effective for these groups, despite high lifetime healthcare expenditures. What are the implications for public health practice?: CRC screening in China can prioritize populations with excess weight and incorporate weight management to improve health outcomes and control long-term healthcare costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.